What we’re watching for in 2019

The J.P. Morgan Health Care Conference, biotech’s annual excuse to crowd an innocent city and wildly prognosticate about the year ahead, is just on the other side of the holidays. And to prepare, we went ahead and made a cheat sheet covering the biggest questions heading into 2019.

That means spelling out the make-or-break clinical trials on the horizon, laying out the challenges ahead for cell and gene therapies, digging into China’s future in biotech, and explaining what might actually happen with drug prices in Congress. There are even charts.

Check out our preview, and, if you’re going to San Francisco for J.P.